13F-HR filed by Stonepine Capital Management, LLC
Stonepine Capital Management, LLC filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 25 holding rows worth $164,570,000.
- Accession
- 0001567619-18-000669
- Filer
- CIK 1440771
- Filed
- 2018-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A holdings report, 25 entries on the cover page, a total value of $164,570,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $164,570,000 with VALUE read as thousands by filing date, 13F file number 028-17175. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOSPECIFICS TECHNOLOGIES | 090931106 | COM | 461,315 | $20,695,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 4,049,298 | $20,166,000 | thousands by filing date | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 2,577,996 | $17,994,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 5,670,205 | $17,521,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 600,000 | $11,430,000 | thousands by filing date | |
| VIVEVE MED INC | 92852W204 | COM NEW | 3,849,711 | $10,471,000 | thousands by filing date | |
| CUMBERLAND PHARMACEUTICALS I | 230770109 | COM | 1,203,339 | $7,376,000 | thousands by filing date | |
| CORREVIO PHARMA CORP | 22026V105 | COM | 1,930,022 | $7,295,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 6,981,184 | $6,830,000 | thousands by filing date | |
| NOVELION THERAPEUTICS INC | 67001K202 | COM NEW | 1,792,911 | $6,598,000 | thousands by filing date | |
| HTG MOLECULAR DIAGNOSTICS IN | 40434H104 | COM | 1,689,064 | $5,506,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 1,912,018 | $5,220,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 1,486,002 | $4,384,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,496,590 | $4,235,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 831,731 | $3,751,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 194,900 | $2,976,000 | thousands by filing date | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 903,224 | $2,692,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P107 | COM | 2,400,000 | $2,302,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 425,531 | $2,213,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 198,373 | $1,393,000 | thousands by filing date | |
| CANCER GENETICS INC. | 13739u104 | COM | 1,391,607 | $1,239,000 | thousands by filing date | |
| GEMPHIRE THERAPEUTICS INC | 36870A108 | COM | 103,000 | $1,050,000 | thousands by filing date | |
| CONFORMIS INC | 20717E101 | COM | 616,109 | $770,000 | thousands by filing date | |
| MELINTA THERAPEUTICS INC | 58549G100 | COM | 52,200 | $331,000 | thousands by filing date | |
| INVIVO THERAPEUTICS HLDGS CO COM | 46186M407 | Stock | 77,900 | $132,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-18-000669 | this filing | 2018-08-14 | acceptance time not in the bulk data set |